Results 201 to 210 of about 42,544 (264)

Hidden Burden of Hepatitis B: High Viral Loads among Asymptomatic Carriers in India. [PDF]

J Glob Infect Dis
Yadav AK, Vishwakarma K, Namdeo D, Tripathi S, Dixit P, Nema S, Biswas D.   +6 more
europepmc   +1 more source

Traditional and Novel Virologic Markers for Functional Cure and HBeAg Loss with Pegylated Interferon in Chronic Hepatitis B: A Systematic Review and Meta-analysis. [PDF]

J Clin Transl Hepatol
Zhang Y, Wang LF, Chen J, Nguyen MH, Zheng Q.   +4 more
europepmc   +1 more source

Detection and characterization of Hepatitis B virus double-stranded linear DNA-derived covalently closed circular DNA in chronic hepatitis B patients. [PDF]

PLoS Pathog
Liu HN, Kim E, Sun N, Wang Z, Nguyen T, Shieh FS, Liu Y, Ghany MG, Chung RT, Sterling RK, Lin SY, Guo H, Lau DTY, Su YH.   +13 more
europepmc   +1 more source

nc886 noncoding RNA regulates hepatitis B virus replication via PKR-dependent eIF2α phosphorylation. [PDF]

Front Cell Infect Microbiol
Piracha ZZ, Saeed U.
europepmc   +1 more source

Altered expression of ADAR1, N4BP1, and PSME1 in PBMCs correlated with therapeutic outcomes in HBeAg-negative chronic hepatitis B patients treated with Peg-IFN-α. [PDF]

Front Cell Infect Microbiol
Pang H, Fu X, Chen L, Yang S, Yang F, Qin B.   +5 more
europepmc   +1 more source

HBsAg and HBcrAg as predictors of HBeAg seroconversion in HBeAg‐positive patients treated with nucleos(t)ide analogues [PDF]

Journal of Viral Hepatitis, 2018
SummaryHBeAg seroconversion marks an important spontaneous change and treatment end‐point for HBeAg‐positive patients and is a pre‐requisite for HBsAg loss or functional cure. In this retrospective analysis, we aimed to identify predictors of seroconversion using serum quantitative HBsAg and HBcrAg, in HBeAg‐positive patients treated with nucleos(t)ide
B. Wang, I. Carey, M. Bruce, S. Montague, G. Dusheiko, K. Agarwal   +5 more
semanticscholar   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa‐2b in HBeAg‐positive patients

Journal of Gastroenterology and Hepatology (Australia), 2010
AbstractBackground and Aim:  To evaluate the usefulness of quantitative hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) for predicting HBeAg seroconversion in chronic hepatitis B patients treated with conventional interferon (IFN) alfa‐2b or PegIFN alfa‐2b.Methods:  Fifty‐eight patients were enrolled; 29 for the training group and
Hui, Ma, Rui-Feng, Yang, Lai, Wei
exaly   +3 more sources

Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferon

Antiviral Research
HBeAg loss is an important endpoint for antiviral therapy in chronic hepatitis B (CHB), however there are no reliable biomarkers to identify patients who will respond to the addition of pegylated interferon to nucleos(t)ide analogue (NA) therapy.To evaluate the use of serum biomarkers to predict HBeAg loss.HBeAg positive CHB participants on NAs who ...
Liang Shen, Pik Eu Chang, Guan-Huei Lee   +2 more
exaly   +3 more sources

Long‐term effect of maternal HBeAg on delayed HBeAg seroconversion in offspring with chronic hepatitis B infection

Liver International, 2011
Abstract Background and aims: This cohort study investigated the long‐term effect of maternal hepatitis B virus (HBV) sero‐status on the spontaneous HBeAg seroconversion in offspring with chronic HBV infection. Methods: A total of 185 HBeAg‐positive chronic HBV‐infected children, with maternal HBV seromarkers checked, were ...
Jia-Feng Wu, Wan-Hsin Wen, Yen-Hsuan Ni   +2 more
exaly   +3 more sources

Discontinuation of nucleot(s)ide analogue therapy in HBeAg-negative chronic hepatitis B: a meta-analysis

Gut, 2021
Background and aims Sustained virological suppression and hepatitis B surface antigen (HBsAg) loss have been described after nucleot(s)ide analogue (NA) discontinuation for patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB ...
S. Hall, Sara Vogrin, Olivia Wawryk, G. Burns, K. Visvanathan, V. Sundararajan, A. Thompson   +6 more
semanticscholar   +1 more source